Skip to main content
. 2019 Dec 3;5:26. doi: 10.1186/s40780-019-0155-1

Table 1.

Usages in package inserts of oral antineoplastic drugsa)

Usage Number of compounds
fasting 15
postprandial 15
before bedtime 1
certain conditions 2
unspecified 39
total 72

a) In addition to what is specified in the package inserts, conditions described in the precautions such as “avoid taking from 1 h before meal until 2 h after meal”, “avoid taking 1 h before and after meal” or “avoid taking from 1 h before meal until 2 h after meal when taking high fat meals” are also classified as “fasting”